Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis

Anticancer Research

Volumn 21, Issue 5, 2001, Pages 3425-3432

  Abou Issa, Hussein M ^a   Alshafie, Galal A ^a   Seibert, Karen ^a   Koki, Alane T ^a   Masferrer, Jaime L ^a   Harris, Randall E ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Celecoxib; Chemoprevention; COX; NSAIDs; Prostaglandin; Rat mammary carcinogenesis

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; ISOENZYMES; MAMMARY NEOPLASMS, EXPERIMENTAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 0035571588     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds
2. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
3. Modulation of rat mammary carcinogenesis by Indomethacin
4. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase-2 inhibitor
5. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models; methods and results from the NCI chemoprevention drug development program
6. Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice
7. Nonsteroidal anti-inflammatory drugs and bladder cancer prevention
8. Piroxicam-induced regression of asoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats
9. Nonsteroidal anti-inflammatory drugs, eicosanoids and colorectal cancer prevention
10. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment
11. Nonsteroidal anti-inflammatory drugs and breast cancer
12. Effect of prostaglandin synthetase inhibitor, Indomethacin, on 7,12-dimethylbenz(a) anthracene-induced mammary tumorigenesis in rats fed different levels of fat
13. Comparative chemopreventive activity of Ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas
14. Growth arrest of DMBA-induced mammary carcinogenesis with Ibuprofen treatment in female Sprague Dawley rats
15. Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinogenesis
16. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
17. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
18. Regulation of eicosanoid production and mitogenesis by transforming growth factor α and phorbol ester
19. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
20. Cyclooxygenase-2 gene expression in human breast cancer
21. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
22. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
23. Prostaglandins and Cancer; A review of tumor initiation through tumor metastasis
24. Prostaglandins and breast cancer
25. Prostaglandins in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells
26. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
27. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells; effects on cell cycle and apoptosis
28. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2
29. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE 2 via cyclic AMP, leading to activation of Promotor II of the CYP-19 (aromatase) gene
30. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens
31. Celecoxib inhibits butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder cancer in male B6D2F1 mice and female Fisher-344rats
32. Persistent induction of cyclooxygenase in p60v-src transformed 3T3 fibroblasts
33. Anti-angiogenic and antitumor activities of cyclooxygenase-2 inhibitors
34. Effects of NSAIDs on proliferation and induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
35. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
36. Non steroidal anti-inflammatory agents: Celecoxib